Pantorilla, Alona D.

HRN: 17-04-05  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2025
MUPIROCIN 2%, 15G (TUBE)
02/01/2025
02/08/2025
TOPICAL
2%
BID
S/P CS
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: